| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $13.8M | -30.0% |
| Cost of Revenue | $12.4M | -12.4% |
| Gross Profit | $1.3M | -75.4% |
| R&D Expense | $551K | -58.8% |
| SG&A Expense | $12.2M | -40.9% |
| Operating Income | -$10.9M | +28.4% |
| Pre-tax Income | -$6.0M | +72.6% |
| Net Income | -$6.7M | +66.4% |
| EPS (Basic) | -$17.23 | -208.8% |
| EPS (Diluted) | -$17.23 | -208.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $757K | +66.7% |
| Accounts Receivable | $480K | -63.1% |
| Inventory | $2.3M | -9.9% |
| Current Assets | $9.0M | -12.7% |
| Total Assets | $19.3M | -30.3% |
| Current Liabilities | $10.5M | -64.5% |
| Long-term Debt | $845K | -83.4% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $258K | +796.2% |
| $17.0M |
| -53.9% |
| Stockholders' Equity | $2.4M | +126.3% |